Purdue eyes patent extension for painkiller OxyContin with study – SmartBrief

Purdue Pharma filed a plan with the NIH to study two daily doses of painkiller OxyContin in more than 150 children ages 6 to 16 with “moderate to severe” pain who need opioid analgesics. The drugmaker aims to submit findings to the FDA and extend its …

Leave a Reply

Your email address will not be published. Required fields are marked *